Detailed answers about ICON CLINICAL RESEARCH (U.K.) LIMITED, including incorporation, status, business activity, and accounts information.
When was ICON CLINICAL RESEARCH (U.K.) LIMITED founded?
ICON CLINICAL RESEARCH (U.K.) LIMITED was officially incorporated on 21 September 1990 and is registered under company number 02541764. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ICON CLINICAL RESEARCH (U.K.) LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ICON CLINICAL RESEARCH (U.K.) LIMITED?
ICON CLINICAL RESEARCH (U.K.) LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ICON CLINICAL RESEARCH (U.K.) LIMITED do?
ICON CLINICAL RESEARCH (U.K.) LIMITED operates in the following sector: 72190 - Other research and experimental development on natural sciences and engineering. This provides insight into the company's primary business activity and industry focus.
What is ICON CLINICAL RESEARCH (U.K.) LIMITED's registered address?
The registered office address of ICON CLINICAL RESEARCH (U.K.) LIMITED is 3RD FLOOR, NORTH & SOUTH WINGS 100 LONGWATER AVENUE, GREEN PARK, READING, BERKSHIRE, UNITED KINGDOM, RG2 6GP. This is the official address filed with Companies House for legal and statutory correspondence.
Is ICON CLINICAL RESEARCH (U.K.) LIMITED financially stable?
The most recent accounts for ICON CLINICAL RESEARCH (U.K.) LIMITED were made up to 31 December 2024, filed as FULL. Next accounts are due by 30 September 2026.